The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Perspectives on barriers and facilitators to minority recruitment for clinical trials among cancer center leaders, investigators, research staff, and referring clinicians: Enhancing minority participation in clinical trials (EMPaCT)
Open accessAbstract
BACKGROUND: The study of disparities in minority recruitment to cancer clinical trials has focused primarily on inquiries among minority populations. Yet very little is known about the perceptions of individuals actively involved in minority recruitment to clinical trials within cancer centers. Therefore, the authors assessed the perspectives of cancer center clinical and research personnel on barriers and facilitators to minority recruitment. METHODS: In total, 91 qualitative interviews were conducted at 5 US cancer centers among 4 stakeholder groups: cancer center leaders, principal investigators, research staff, and referring clinicians. All interviews were recorded and transcribed. Qualitative analyses of response data was focused on identifying prominent themes related to barriers and facilitators to minority recruitment. RESULTS: The perspectives of the 4 stakeholder groups were largely overlapping with some variations based on their unique roles in minority recruitment. Four prominent themes were identified: 1) racial and ethnic minorities are influenced by varying degrees of skepticism related to trial participation, 2) potential minority participants often face multilevel barriers that preclude them from being offered an opportunity to participate in a clinical trial, 3) facilitators at both the institutional and participant level potentially encourage minority recruitment, and 4) variation between internal and external trial referral procedures may limit clinical trial opportunities for racial and ethnic minorities. CONCLUSIONS: Multilevel approaches are needed to address barriers and optimize facilitators within cancer centers to enhance minority recruitment for cancer clinical trials. Cancer 2014;120(7 suppl):1097–105. © 2014 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review
Ford, J. G., Howerton, M. W., Lai, G. Y., Gary, T. L., Bolen, S., Gibbons, M. C., Tilburt, J., Baffi, C., Tanpitukpongse, T. P., Wilson, R. F., et al. (2008) · Cancer · doi:10.1002/cncr.23157 · Cited by 1,083
Cited by
Diversity in clinical and biomedical research: a promise yet to be fulfilled
Oh, S. S., Galanter, J., Thakur, N., Pino-Yanes, M., Barcelo, N. E., White, M. J., de Bruin, D. M., Greenblatt, R. M., Bibbins-Domingo, K., Wu, A. H. B., et al. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001918 · Cited by 585
Heller, C., Balls-Berry, J. E., Nery, J. D., Erwin, P. J., Littleton, D., Kim, M., & Kuo, W. P. (2014) · Contemporary Clinical Trials · doi:10.1016/j.cct.2014.08.004 · Cited by 290
Lee, S. S.-J., Cho, M. K., Kraft, S. A., Varsava, N., Gillespie, K., Ormond, K. E., Wilfond, B. S., & Magnus, D. (2019) · Genetics in Medicine · doi:10.1038/s41436-018-0032-6 · Cited by 129
Niranjan, S. J., Wenzel, J. A., Martin, M. Y., Fouad, M. N., Vickers, S. M., Konety, B. R., & Durant, R. W. (2021) · JCO Oncology Practice · doi:10.1200/op.20.00970 · Cited by 62
Self-citationCosta, L. J., Hari, P. N., & Kumar, S. K. (2016) · Leukemia & Lymphoma · doi:10.3109/10428194.2016.1170828 · Cited by 57
Nouvini, R., Parker, P. A., Malling, C. D., Godwin, K., & Costas‐Muñiz, R. (2022) · Cancer · doi:10.1002/cncr.34454 · Cited by 56
Cudjoe, J., Turkson-Ocran, R.-A., Ezeigwe, A. K., Commodore-Mensah, Y., Nkimbeng, M., & Han, H.-R. (2019) · Journal of Community Health · doi:10.1007/s10900-019-00677-y · Cited by 41
Nyenhuis, S. M., Balbim, G. M., Ma, J., Marquez, D. X., Wilbur, J., Sharp, L. K., & Kitsiou, S. (2020) · JMIR Formative Research · doi:10.2196/13900 · Cited by 18
Baggett, K. M., Davis, B., Sheeber, L. B., Ammerman, R. T., Mosley, E. A., Miller, K., & Feil, E. G. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17238978 · Cited by 15
Stockdill, M. L., Dionne-Odom, J. N., Wells, R., Ejem, D., Azuero, A., Keebler, K., Sockwell, E., Tims, S., Burgio, K. L., Engler, S., et al. (2023) · Journal of Palliative Care · doi:10.1177/0825859720975978 · Cited by 11
Self-citationPerceptions of clinical care and research among African-American patients with lymphoma
Dance, K. V., Imbody, C. B., Chen, L., McNeill, L., Payne, J. B., & Flowers, C. R. (2021) · Leukemia & Lymphoma · doi:10.1080/10428194.2021.1892092 · Cited by 7
Monreal, I., Chappell, H., Kiss, R., Friedman, D. R., Akesson, J., Sae-Hau, M., Szumita, L., Halwani, A., & Weiss, E. S. (2025) · Military Medicine · doi:10.1093/milmed/usae441 · Cited by 6
Metadata
- Authors
- Durant, R. W., Wenzel, J. A., Scarinci, I. C., Paterniti, D. A., Fouad, M. N., Hurd, T. C., & Martin, M. Y.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2014-03-18
- Volume
- 120
- Issue
- S7
- Pages
- 1097-1105
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1497584606
- Cited by
- 191
- References
- 1
- FWCI
- 10.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.